COMMUNIQUÉS West-GlobeNewswire

Arcturus Therapeutics Announces Expansion of Collaboration with Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH) and Other GI Disorders
17/01/2018
SAN DIEGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, announced today that it is extending its partnership with Takeda Pharmaceutical Company Limited ( [...]
NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology
17/01/2018
WALTHAM, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) announced today a collaboration with GlaxoSmithKline (NYSE: GSK ), one of the world's largest science-led global healthcare companies, [...]
Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris
17/01/2018
~ MACRILEN is the First and Only FDA-Approved Oral Drug Indicated For the Diagnosis of Adult Growth Hormone Deficiency, a Rare Endocrine Disorder ~ ~ MACRILEN is Strongbridge’s Second Commercial Product; Expands the [...]
Aeterna Zentaris Enters into Licensing and Assignment Agreement with Strongbridge for Macrilen™ (macimorelin) in the U.S. and Canada
17/01/2018
CHARLESTON, S.C., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) announced today that it has, through a wholly-owned subsidiary, entered into a license and assignment agreement with [...]
Natus Medical to Hold 2017 Fourth Quarter Financial Results Conference Call on February 7th
17/01/2018
PLEASANTON, Calif., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that the Company will release its 2017 fourth quarter financial results before the market opens on [...]
RedHill Biopharma and Express Scripts Subsidiary Inside Rx Add EnteraGam® to Savings Program for Uninsured or Underinsured Patients
17/01/2018
TEL-AVIV, Israel and RALEIGH, N.C., Jan. 17, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients
17/01/2018
On Track to Report Top-Line Data from Phase 2b Trial in Second Quarter of 2018 LIVONIA, Mich., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company [...]
In 2018 “Grindeks” forecasts at least 10% increase in turnover
17/01/2018
Joint Stock Company “Grindeks” informs, it is expecting to reach at least 10% increase in turnover in 2018, comparing with the results of 2017. In 2018, “Grindeks” will strategically focus on complex solutions to meet [...]
Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China
17/01/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics, today [...]
OraSure Technologies Earnings Conference Call Invitation
17/01/2018
2017 Fourth Quarter Earnings Conference Call Wednesday, February 7, 2018, 5:00 p.m. ET BETHLEHEM, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ) has scheduled its regular earnings [...]
MDxHealth: Shareholder Transparency Declaration
17/01/2018
NEWS RELEASE REGULATED INFORMATION INSIDE INFORMATION MDxHealth: Shareholder Transparency Declaration HERSTAL, BELGIUM and IRVINE, CA- January 17, 2018 - MDxHealth SA (Euronext: MDXH.BR) today announced that, that it [...]
MDxHealth: Déclaration de transparence d'un actionnaire
17/01/2018
COMMUNIQUE DE PRESSE INFORMATION REGLEMENTAIRE INFORMATION PRIVILIGIEE MDxHealth: Déclaration de transparence d'un actionnaire HERSTAL, BELGIUM and IRVINE, CA- Le 17 janvier, 2018 - MDxHealth SA (Euronext: MDXH.BR) a [...]
Novartis granted US FDA Priority Review for Kymriah(TM) (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL
17/01/2018
Filing acceptance marks second Priority Review granted to Kymriah by the FDA for two distinct indications, underscoring the potential of first ever FDA-approved CAR-T therapy EMA granted accelerated assessment to [...]
HalioDx closed a Series B round of €18.5 million (US$22.3 million)
17/01/2018
Press release janUARY 17, 2018 HalioDx closed a Series B round of €18.5 million (US$22.3 million) This funding will accelerate the development of Immunoscore® in selected cancers, and support set up of commercial [...]
HalioDx lève 18,5 millions d'euros dans un tour de Série B
17/01/2018
Communiqué de presse 17 janvier 2018 HalioDx lève 18,5 millions d'euros dans un tour de Série B Ce financement permettra à HalioDx d'accélérer le développement d'Immunoscore® dans différents cancers et d'accompagner son [...]
AzurRx BioPharma Receives $2 Million in Proceeds from Exercise of Warrants
17/01/2018
BROOKLYN, N.Y., Jan. 16, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
AveXis Announces Pricing of Public Offering of Common Stock
17/01/2018
CHICAGO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ) today announced the pricing of an underwritten public offering of 3,921,600 shares of its common stock at a public offering price of $102.00 per [...]
CORRECTION -- Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum
17/01/2018
SEATTLE, Jan. 16, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline on December 21, 2017 by Arzeda, we are advised by the company that "OP Fund" in the second paragraph should have read "OS Fund." The [...]
SENS Research Foundation 2017 Year End Fundraiser Achieves Over $5 Million in Donations
17/01/2018
MOUNTAIN VIEW, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- SENS Research Foundation (SRF), a leading Silicon Valley nonprofit focused on diseases of aging, announced today that it received over $5 Million in donations [...]

Pages